Fannin Ltd are proud to introduce the new Espiner SuitORpass, the disposable suture passer and guide. Port-site complications can occur in 1% to 6% of cases. Since the first report of hernia development at a trocar site after laparoscopy, many techniques and devices have been introduced into practice to minimize this risk*.

The SuitORpass disposable suture passer with guide can be used in the closure of the fascia as it accurately passes the suture material through all fascial layers, potentially preventing incisional hernias. The SuitORpass facilitates the complete and secure closure of operative incisions of 10mm or larger, subsequently reducing the risk of developing a hernia postoperatively.

If you wish to learn more about the SuitORpass please visit the laparoscopic instruments section of our website for further information or contact the office for details.

Brought to you by Fannin Ltd the Espiner Trocar is designed for precision and control providing safe and straightforward access to the peritoneal cavity.

Benefits of the Espiner Trocar Include:

• Smooth entry with low insertion force into the abdominal cavity
• Funnel design enables smooth instrument exchange and specimen removal
• Clear housing provides surgeon precise visibility of trocar positioning
• Blade indicator window to highlight when the blade is activated
• Thread design maintains the seal & helps ensure a leak-free operation

If you wish to learn more about the Espiner Trocar please visit the laparoscopic instruments section of our website for further information or contact the office for details.

Fannin Ltd provides a comprehensive laparoscopic & theatre essentials range to support healthcare professionals across the UK and Ireland.

Our extensive range has been developed following consultation with healthcare professionals, ensuring we provide quality products at a cost-effective price, helping to maximise theatre productivity and efficiency.

Every item in our laparoscopic and theatre range has been sourced and developed to enable clinicians to provide the highest level of care to their patients during surgical procedures.

If you are interested in finding out more about our laparoscopic range, please fill out the enquiry form using the link below, and a product specialist will be in touch.

Dear Customer,

Thank you for your enquiry in relation to our position on the outbreak of Novel Coronavirus (Covid-19). DCC Vital recognises the seriousness of this matter and we continue to closely monitor the situation as it develops. We clearly understand that the matter has impacted the health service, patients, suppliers and our employees in different ways, depending on their location and supply channels. Please refer to Appendix for DCC Vital businesses to which this statement relates.

As a market leader in healthcare in the UK and Ireland, DCC Vital understands the risk to the population is significant. However, we are actively supporting and working with the Departments of Health in both Ireland and the UK as well as HSE, NHS and all key suppliers to provide any needed medical devices and medicines to care for affected patients and to protect others.

Monitoring

Our Pandemic Continuity Group are continually reviewing, planning and taking the necessary actions in consideration of the changing situation. This group is currently meeting daily to review national and international updates and revised guidelines. Our businesses have continuity plans in place and these are under continuous review to ensure continuity of supply and services.

We are closely monitoring reference websites on the emerging situation including the following:

ROI: https://www2.hse.ie/conditions/coronavirus/coronavirus.html

• England & Wales: https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public
• Scotland: https://www.gov.scot/coronavirus-covid-19/
• WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public

Some of the measures we have taken to ensure continuity of supply are set out below.

Stock availability and logistics

We are satisfied that our plan for stock is sufficient to cope with increased demand, and our current average stock holding meets the HSE & NHS requirement. We are in regular contact with our suppliers to ensure continuity of supply is maintained.  We have a multi supplier policy within the business to minimise risk. Where possible, we have plans in place with suppliers to enable dual sourcing of key product lines. We continue to monitor risk within the supply chain. To date we have not been informed of any adverse issues likely to negatively impact on the supply chain. We believe that we can maintain continuity of supply for our products.

Travel

As a precautionary measure, all business travel has been ceased including non-essential movement between our sites. Our business is using phone and video-conferencing to maintain necessary communications with our staff and stakeholders.

Hygiene

As part of our Health & Safety programme, we are communicating and implementing best practice hygiene measures with our staff in line with WHO and Department of Health recommendations.

Facilities

We have additional facilities in Ireland and the UK and therefore have the option to use these facilities where it may be deemed necessary to ensure continuity of supply for our entire business. Our systems facilitate remote working of our employees should this be required.

Please be assured that we will continue to do all in our control to minimise risk, so as to ensure an uninterrupted supply chain and thus provide you with the service you require.

On behalf of: DCC Vital Pandemic Continuity Group

APPENDIX. DCC VITAL Businesses

Fannin Limited

• Fannin (NI) Limited
• Fannin (UK) Limited Medisource Limited
• Williams Medical Limited
• SP Services Limited
• Vacsax UK Limited
• TPS Healthcare Group Limited
• Squadron Medical Limited

We’re exhibiting at this year’s BSGE Annual Scientific Meeting 21-23^rd May, Celtic Manor, Newport

Visit our booth to see our unique range of patented tissue retrieval sacs and morcellation containment systems; incorporating the latest design technology for materials and at the cutting edge of minimally invasive surgery. We look forward to meeting you there..

Official event site – https://asm.bsge.org.uk/

The Fannin UK Ltd: Espiner team are excited to be a part of the 47th AAGL Global Congress on Minimally Invasive Gynaecological Surgery. 11th-15th November 2018 at the MGM Grand Hotel & Casino Las Vegas

Visit us at Booth #930 to meet the Espiner and Global Medical Partners team.

See our unique range of patented tissue retrieval sacs and morcellation containment systems; incorporating the latest design technology for materials and at the cutting edge of minimally invasive surgery. To arrange an appointment with us please email espiner@fannin.eu or drop by to see us.

Visit the official event site – https://2018.aagl.org/

Espiner Distributor Breakfast Meeting: Medica 2017

During this year’s Medica, Espiner Medical hosted a distributor breakfast meeting at the Tulip Inn Hotel, Düsseldorf.  The event enabled Espiner to bring together our distributor network from around the world, including Canada, Saudi Arabia, Russia, Norway and many more. It was a valuable opportunity to discuss market trends and for our distribution network to share different strategies employed globally.

The meeting provided an ideal opportunity to update our distributors on some of the new structures and improvements being made within the business. The meeting included presentations from:

Enda Scott – Managing Director, Medical Devices

Pat Tracey – Group Operations Director

Anthony Roots – Head of International Sales

Kirstie Eydes – Head of Regulatory

Dave Groombridge – Marketing Manager

We would like to say thank you to everyone who attended for taking the time from their busy schedules and look forward to working with you all to grow the business in 2018!

Why contain Morcellation?

• May reduce disseminated malignancy rates
• Sac creates chamber to isolate tissue for morcellation
• Prevent bowel injury
• May reduces risk of Endometriosis & Peritoneal Myomatosis
• Reduces procedure time. Tissue/blood residue is contained and removed on sac extraction
• Better patient experience & reduced stay in hospital
• Improves clinician confidence

Features:

Background

Morcellation refers to the division of tissue into smaller pieces or fragments and is often used during  Gynaecological laparoscopic surgeries to facilitate the removal of tissue through small incision sites. When used for a hysterectomy or myomectomy in women with uterine fibroids, laparoscopic power morcellation poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus. This was found to be at a risk of 1 in 350 patients as quoted by the FDA (www.FDA.gov 2014), however, others have reported that this risk is 1 in 2000 (Pritts et al.2015). Yet, many women choose to undergo laparoscopic hysterectomy or myomectomy due to benefits such as a shorter post-operative recovery time and hospitalization, a reduced risk of infection, decreased bleeding and decreased post-operative pain.

The Espiner ECO-T Containment Bag (which is CE marked) includes an accessory sleeve, allowing the surgeon to morcellate within the sac, thus entirely contained, under direct visualization (by placing the laparoscope through the accessory sleeve). As the tissue is totally contained during the process, this minimizes the risk of potentially spreading the morcellated tissue. Post procedure, the sac and contents are extracted from the abdomen, and the surgeon is able complete the procedure without the need to find lost morcellated pieces.

References
Pritts, E.A., Vanness, D.J., Berek, J.S. et al. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg (2015) Volume 12, Issue 3, pp 165–177

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm393689.htm#

IMSTA 2016 award for most innovative product

The Espiner Morcellation Containment System was designed in 2014, after the FDA published guidance on the use of laparoscopic powered morcellators in women with unsuspected uterine sarcomas and the spread of cancerous tissue within the abdomen & uterus.

This sac (which is CE marked and available for sale in Europe) includes a secondary port, allowing the surgeon capture the tissue and safely morcellate within the sac under direct visualization. The tissue is contained during the process, minimising the risk of contamination from excised tissue. Post procedure, the sac and contents are extracted from the body, without having to go in to ‘clean up’.

The Irish Medical & Surgical Trade Association Annual awards ceremony took place on 3^rd October 2016, where Fannin were proud winners of the most innovative product award.

Read full story here:

Fannin Wins IMSTA 2016 Most Innovate Product Award

Espiner Spring Distributor Conference 14TH -16TH APRIL 2016

This year Espiner’s distributor meeting was held in the United Kingdom, near our factory in Clevedon.

The conference consisted of:

•      A factory tour to show our distributors the manufacture of the Espiner Sacs
•      Intensive product training
•      New product Development
•      Live morcellation workshop – Presented by Consultant Gynaecologist Mr   Ben Peyton-Jones
•      Paediatrics Lecture – Presented by Consultant Paediatric Surgeon Mr Oliver Gee
•      Question & Answer session

On 8th October 2015 Espiner Medical became incorporated into the Medical Devices division of Fannin UK Ltd, which is part of DCC Vital. Fannin have been a distributor for Espiner Medical products for over 15 years. Espiner products are sold under the Espiner Medical brand for Fannin UK Ltd.

Espiner’s annual Global Distributor Meeting was again held at the Tulip Hotel at Medica, in Düsseldorf.

Both prospective and existing distributors were in attendance including those from Europe, Russia and Canada.

New this year saw excellent presentations from:

• Prof, dr Zdravko Perko, MD, PhD, of Doctum Surgical, Croatia
• Jochen Gerbershagen of IFM Gerbershagen, Germany.

Subjects covered included:

• Medical Device Product testing protocols
• Surgeon presentations
• Distributor Marketing Practices
• Latest news & developments
• Interactive Discussion forum

Espiner medical launches new & improved Kombi Introducer system for its popular 10mm and new 12mm Master E-Sac range.

Espiner announced the launch of its new, precision engineered, injection moulded, introducer system at its Distributor meeting held to coincide with Medica 2013 in Düsseldorf.

The new and improved design incorporates the following features:

New tactile markers:

• ‘TOP’on the finger-loop means you can tell by, touch alone, the orientation of the mouth
• Espiner logo on one side of the valve block to aid orientation.
• Now embossed on the delivery system;

Better control:

• Finger loop now locks into to the valve block, giving  you one-handed control of the sac and cannula.
• New ‘soft feel’ grip strips on the side of the valve block prevent slipping and lets you handle the instrument securely – even with wet gloves.

 Safer and more secure:

• The blue loop has been replaced with a simple but strong button hole; this is much easier to detach from the finger loop and is more secure.
• Monofilament drawstring closure.

Stronger and more versatile:

• We have strengthened the arms of the rod.
• Since it is a little sturdier, the instrument can now be used to scoop, turn over and snare tissue.

  How these changes benefit you:

• Superior product.
• Fully recyclable – disposal costs have been reduced
• Comprehensively tested to the highest possible safety standards.

Master E-sac Order Codes

Espiner Medical’s Annual Distributor Meeting was again held at the Tulip Hotel at Medica, in Düsseldorf.

Both prospective and existing distributors were in attendance, from Europe, Australia, New Zealand, America, Canada & China.

Subjects covered included:

• Product developments, new developments and presentations.
• Espiner Medical’s receipt of the Queens Award for Enterprise International Trade
• The launch of the new “Introducer System” & Master E-Sac range WG’s
• Latest developments in Bar Coding
• Fabric Technology

Espiner Medical Distributor Meeting – Düsseldorf, Germany

In 2013 Espiner Medical won the Queens Award for Enterprise – International Trade Export; achieved by increasing our exports by a staggering 1517% over the previous 6 year period.